ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

DCE Advisors Okay Contract Recompetitions For Epidemiology

November 18, 1994

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006